发明名称 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and 53
摘要 A compound of formula (1), wherein: R5 is hydrogen, C1-4alkyl, R6CH2- or R6C(O)-; R6 is aryl, heteroaryl, heterocyclyl, aminoC3-6alkyl, N-(C1-4alkyl)aminoC3-6alkyl, NN-(diC1-4alkyl)aminoC3-6alkyl, or R7; wherein the aryl, heteroaryl or heterocyclyl rings may be optionally substituted with up to three substituents independently selected from nitro, C1-4alkyl, C1-4alkoxy, halo, (C1-4alkyl)sulfanyl, C1-4alkoxycarbonyl, N-(C1-4alkyl)carbamoyl, NN-(diC1-4alkyl)carbamoyl, N-(C1-4alkyl)amino or NN-(diC1-4alkyl)amino; wherein R7 is either a group or formula (2) or formula (3); and wherein L1, L2, L3, L4, R1, R2, R3, R4, R8, R9, R10, R11, R12, R13, A1, n, p, q, r and s are as defined herein. The compounds of formula (1) inhibit the interactions between MDM2 and p53 and may be useful in the treatment of cancers.
申请公布号 AU5751299(A) 申请公布日期 2000.04.03
申请号 AU19990057512 申请日期 1999.09.07
申请人 ASTRAZENECA UK LIMITED 发明人 RICHARD WILLIAM ARTHUR LUKE;PHILIP JOHN JEWSBURY;RONALD COTTON
分类号 C07D295/18;A61K31/495;A61K31/496;A61K38/00;A61P35/00;C07D209/20;C07D295/185;C07D401/12;C07D405/12;C07D409/12;C07D417/12;C07K5/09 主分类号 C07D295/18
代理机构 代理人
主权项
地址